MedPath

Surgical Resection Lowers Oxidative Stress Markers in Patients With Colorectal Cancer

Not Applicable
Completed
Conditions
Colorectal Cancer
Colon Rectal Resection
Oxidative Stress
Interventions
Procedure: Surgery for colorectal cancer
Registration Number
NCT01470586
Lead Sponsor
G. Hatzikosta General Hospital
Brief Summary

Study of Oxidative stress Markers (F2 Isoprostanes for lipid peroxidation, Carbonyl groups for protein peroxidation, 3 Nitrotyrosine for damage by nitrogens, and 8-Hydroxyguanosine for RNA peroxidation)in patients with colorectal cancer undergo surgical treatment (preoperatively during the intervention and postoperatively) and controls.

Detailed Description

Study of the impact of surgery on Lipid peroxidation, Protein peroxidation, damage by nitrogens, and RNA peroxidation, in patients undergo surgical resection for colorectal cancer and compared with controls, and validation of the responsiveness of oxidative stress markers on surgery

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients with colorectal cancer
  • Controls
Exclusion Criteria
  • ASA>3
  • Metastatic Disease
  • Acute bowel obstruction
  • Acute bowel perforation
  • BMI<30
  • Chronic Systemic or Autoimmune Diseases
  • Smokers
  • Alcohol consumers

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Surgery for colorectal cancerSurgery for colorectal cancerColorectal cancer patients
Primary Outcome Measures
NameTimeMethod
Comparison of Oxidative stress markers in patients with colorectal cancer and controlsup to 2 years

Oxidative stress markers variation (8-PGF2α, Protein Carboyls, 3-Nitrotyrosine, 8-OHG) during and after surgery for colorectal cancer, and compare with controls

Secondary Outcome Measures
NameTimeMethod
Validation of oxidative stress markers in patients with colorectal cancer undergo surgical resectionup to 2 years

Validation of the responsiveness of markers of oxidative stress 8-PGF2α, Protein Carboyls, 3-Nitrotyrosine, 8-OHG)on surgery

Trial Locations

Locations (1)

G. Hatzikosta General Hospital

🇬🇷

Ioannina, Epirus, Greece

© Copyright 2025. All Rights Reserved by MedPath